Kite’s CAR-T cancer therapy shows strong results as company races to win FDA approval – STAT
STAT |
Kite's CAR–T cancer therapy shows strong results as company races to win FDA approval
STAT The treatment involves filtering a patient's blood to remove key immune system soldiers called T–cells, altering them in the lab to contain a gene that targets cancer, and giving them back intravenously. Doctors call it a “living drug” — permanently … Kite Pharma (KITE) Reports Positive Topline Data on Axicabtagene Ciloleucel from First Pivotal CAR–T Trial in … Gene therapy to fight a blood cancer succeeds in major study Ahead of Q4 Financials, Analysts are Upbeat about Kite Pharma … |
